Serum levels of hepcidin in patients with biopsy-proven nonalcoholic fatty liver disease.

@article{enate2011SerumLO,
  title={Serum levels of hepcidin in patients with biopsy-proven nonalcoholic fatty liver disease.},
  author={Ebubekir Şenateş and Yusuf Yilmaz and Yaşar Çolak and O. Cem Ozturk and Mustafa Erhan Altunoz and Ramazan Kurt and Selvinaz Ozkara and Sebahat Aksaray and Ilyas Tuncer and Ayse Oya Kurdas Ovunc},
  journal={Metabolic syndrome and related disorders},
  year={2011},
  volume={9 4},
  pages={287-90}
}
BACKGROUND Research suggests the presence of mild-to-moderate iron overload in patients with nonalcoholic fatty liver disease (NAFLD). The role played by hepcidin, the master regulatory hormone of systemic iron metabolism, in the pathogenesis of NAFLD remains controversial. The aims of this study were to: (1) Evaluate serum hepcidin levels in patients with biopsy-proven NAFLD and age- and sex-matched controls and (2) identify the potential associations of hepcidin with the clinical and… CONTINUE READING
18 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

Similar Papers

Loading similar papers…